Loading...
Market
Didier Raoult to publish new COVID-19 treatment study by end of 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Academic journals and publication databases
Story
Didier Raoult's IHU Marseille Hydroxychloroquine Study Officially Retraction Ends Five-Year COVID-19 Controversy
Dec 17, 2024, 10:34 AM
The prominent study on hydroxychloroquine conducted by Professor Didier Raoult and the IHU in Marseille has been officially retracted, marking a significant setback for proponents of this treatment for COVID-19. This research had been a cornerstone for supporters of hydroxychloroquine over the past five years, but recent developments have led to its invalidation. Critics have long argued that the study should have been retracted much earlier, reflecting ongoing controversies surrounding the drug's efficacy against the virus. The retraction signifies a culmination of nearly five years of debate regarding the use of hydroxychloroquine in treating COVID-19.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
The Lancet • 25%
New England Journal of Medicine • 25%
Nature • 25%
Other • 25%
Yes • 50%
No • 50%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
